This edition contains the following:
Read MoreThis edition contains the following: New Adult Hep B Vaccine Approved! Treatment for Refractory Post-Transplant CMV Infection Now Available Alcohol Related Liver Disease in Women Liver Spot: Hepatitis D Meet
Read MoreThis edition contains the following: TLI Welcomes Dr. Rita Lepe, Director of Hepatology Health Disparities Studies Hispanics and Liver Disease So Close But Yet So Far…Promising Drugs That Came Up
Read MoreThis edition contains the following: First FDA-Approved NASH Drug Expected in 2020: Quick Facts to Know The Tussle Between Resection and Liver Transplantation in the Treatment of HCC “What advice
Read MoreThis edition contains the following: Living Donor Liver Transplantation An Update on Nonalcoholic Steatohepatitis (NASH) from the International Liver Congress Does direct-acting antiviral exposure affect hepatocellular carcinoma recurrence in patients
Read MoreThis edition contains the following: A New First-Line Oral Treatment for Advanced Hepatocellular Carcinoma Comprehensive, Cutting-Edge Care at The Texas Liver Tumor Center An Update on the Management of Severe
Read MoreThis edition contains the following: Autoimmune Hepatitis: Current And Future Treatment Options Cholangiocarcinoma: Diagnosis And Management Is Green Tea Good For Your Health? What Noninvasive Imaging Techniques Can Measure Liver
Read MoreThis edition contains the following: New Targeted Therapy for HCC Can my patients take over-the-counter herbal and dietary supplements? NAFLD/NASH Update
Read MoreThis edition contains the following: TLI Welcomes Dr. Fabian Rodas Opening of Texas Liver Tumor Center (TLTC) HCC in South Texas Latinos: Is Aflatoxin Exposure Partly to Blame? A Focus on Benign
Read MoreThis edition contains the following: Dr. Naim Alkhouri, Joins Texas Liver Institute and UT Health Oral Nutrition Supplement for a Patient with Cirrhosis How to Make Low Sodium Diet Appealing to Patients Hepatitis
Read More- 1
- 2